AstraZeneca COVID-19 vaccine 76% effective in updated US trial results

British drugmaker AstraZeneca Plc said on Thursday its vaccine was 76% effective in preventing symptomatic COVID-19 and that it has submitted the results to the US Data and Safety Monitoring Board.
The development comes after health officials publicly criticized the drugmaker for using "outdated information" to show how well the immunization worked.  
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy